Loading organizations...
Drug discovery using bacTRAP technology for targeted therapies.
Envoy Therapeutics has raised $9.2M across 2 funding rounds.
Envoy Therapeutics has raised $9.2M in total across 2 funding rounds.
Envoy Therapeutics has raised $9.2M in total across 2 funding rounds.
Envoy Therapeutics's investors include The Michael J. Fox Foundation for Parkinson's Research, 5AM Ventures, Roche, Takeda Ventures.
Envoy Therapeutics has raised $9.2M across 2 funding rounds. Most recently, it raised $1.2M Grant in May 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 8, 2012 | $1.2M Grant | The Michael J. Fox Foundation for Parkinson's Research | |
| Oct 14, 2009 | $8.0M Series A | 5AM Ventures | Roche, Takeda Ventures |